Liquidia Corp (LQDA)
12.79
-0.19
(-1.46%)
USD |
NASDAQ |
May 03, 16:00
12.78
0.00 (0.00%)
After-Hours: 20:00
Liquidia Cash and Short Term Investments (Quarterly): 83.68M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 83.68M |
| September 30, 2023 | 76.22M |
| June 30, 2023 | 88.20M |
| March 31, 2023 | 94.41M |
| December 31, 2022 | 93.28M |
| September 30, 2022 | 98.32M |
| June 30, 2022 | 103.84M |
| March 31, 2022 | 57.79M |
| December 31, 2021 | 57.49M |
| September 30, 2021 | 64.05M |
| June 30, 2021 | 67.89M |
| March 31, 2021 | 53.64M |
| December 31, 2020 | 65.32M |
| Date | Value |
|---|---|
| September 30, 2020 | 79.55M |
| June 30, 2020 | 23.59M |
| March 31, 2020 | 40.13M |
| December 31, 2019 | 55.80M |
| September 30, 2019 | 39.30M |
| June 30, 2019 | 52.12M |
| March 31, 2019 | 60.81M |
| December 31, 2018 | 39.54M |
| September 30, 2018 | 47.52M |
| June 30, 2018 | 9.232M |
| March 31, 2018 | 17.59M |
| December 31, 2017 | 3.419M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
23.59M
Minimum
Jun 2020
103.84M
Maximum
Jun 2022
68.14M
Average
65.32M
Median
Dec 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| United Therapeutics Corp | 2.708B |
| AIM ImmunoTech Inc | 13.07M |
| Perspective Therapeutics Inc | 9.238M |
| Protalix BioTherapeutics Inc | 44.56M |
| Armata Pharmaceuticals Inc | 13.52M |